|
End-of-day quote
Borsa Italiana
2026-08-20
|
5-day change | 1st Jan Change | ||
| 165.10 EUR | +2.51% |
|
+0.67% | +20.00% |
| 08-21 | Philip Morris Reports FDA Authorization for ZYN ULTRA Nicotine Pouches | MT |
| 08-21 | FDA Approves 11 Philip Morris Zyn Ultra Pouches | DJ |
Company Valuation: Philip Morris International Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 147,899 | 156,896 | 146,050 | 187,124 | 249,685 | 293,378 | - | - |
| Change | - | 6.08% | -6.91% | 28.12% | 33.43% | 17.5% | - | - |
| Enterprise Value (EV) 1 | 171,209 | 196,812 | 190,899 | 228,603 | 293,648 | 334,608 | 332,425 | 330,508 |
| Change | - | 14.95% | -3% | 19.75% | 28.45% | 13.95% | -0.65% | -0.58% |
| P/E | 16.3x | 17.4x | 18.7x | 26.6x | 22.1x | 25.4x | 21.9x | 19.6x |
| PBR | -14.6x | -17.5x | -13x | -15.9x | -25x | -43.4x | -62.5x | -92x |
| PEG | - | -50.72x | -1.4x | -2.67x | 0.4x | 11.49x | 1.4x | 1.7x |
| Capitalization / Revenue | 4.71x | 4.94x | 4.15x | 4.94x | 6.14x | 6.75x | 6.38x | 6.02x |
| EV / Revenue | 5.45x | 6.2x | 5.43x | 6.04x | 7.22x | 7.7x | 7.23x | 6.78x |
| EV / EBITDA | 11.8x | 14.3x | 13.5x | 14.7x | 16.9x | 17.2x | 16x | 15.1x |
| EV / EBIT | 12.7x | 15.2x | 14.3x | 15.6x | 17.9x | 18.7x | 17.3x | 16x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 4.9 | 5.04 | 5.2 | 5.4 | 5.64 | 5.99 | 6.391 | 6.756 |
| Rate of return | 5.16% | 4.98% | 5.53% | 4.49% | 3.52% | 3.18% | 3.4% | 3.59% |
| EPS 2 | 5.83 | 5.81 | 5.02 | 4.52 | 7.26 | 7.42 | 8.613 | 9.598 |
| Distribution rate | 84% | 86.7% | 104% | 119% | 77.7% | 80.7% | 74.2% | 70.4% |
| Net sales 1 | 31,405 | 31,762 | 35,174 | 37,878 | 40,648 | 43,455 | 45,976 | 48,722 |
| EBITDA 1 | 14,486 | 13,802 | 14,193 | 15,580 | 17,375 | 19,467 | 20,740 | 21,946 |
| EBIT 1 | 13,488 | 12,908 | 13,337 | 14,688 | 16,428 | 17,862 | 19,223 | 20,656 |
| Net income 1 | 9,109 | 9,048 | 7,813 | 7,057 | 11,348 | 11,586 | 13,423 | 14,924 |
| Net Debt 1 | 23,310 | 39,916 | 44,849 | 41,479 | 43,963 | 41,230 | 39,047 | 37,130 |
| Reference price 2 | 95.00 | 101.21 | 94.08 | 120.35 | 160.40 | 188.23 | 188.23 | 188.23 |
| Nbr of stocks (in thousands) | 1,556,828 | 1,550,202 | 1,552,406 | 1,554,833 | 1,556,639 | 1,558,613 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/6/25 | 2/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.37x | 7.7x | 17.19x | 3.18% | 293B | |
| 12.37x | 4.53x | 9.74x | 6.07% | 121B | |
| 9.42x | 2.78x | 6.38x | 6.67% | 25.91B | |
| 36.85x | 2.76x | 24.03x | 1.62% | 7.86B | |
| 65.16x | 3.11x | 22.82x | 0.38% | 1.67B | |
| 14.15x | - | - | - | 1.12B | |
| Average | 27.22x | 4.18x | 16.03x | 3.59% | 75.24B | |
| Weighted average by Cap. | 21.27x | 6.46x | 14.70x | 4.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PM Stock
- 1PM Stock
- Valuation Philip Morris International Inc.
Select your edition
All financial news and data tailored to specific country editions
